Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells.

Stover T, Kester M.

J Pharmacol Exp Ther. 2003 Nov;307(2):468-75.

2.

Pegylated liposomal doxorubicin in the treatment of breast cancer.

O'Shaughnessy JA.

Clin Breast Cancer. 2003 Dec;4(5):318-28. Review.

PMID:
14715106
3.

Future directions of liposome- and immunoliposome-based cancer therapeutics.

Park JW, Benz CC, Martin FJ.

Semin Oncol. 2004 Dec;31(6 Suppl 13):196-205. Review.

PMID:
15717745
4.

Ceramide-based therapeutics for the treatment of cancer.

Barth BM, Cabot MC, Kester M.

Anticancer Agents Med Chem. 2011 Nov;11(9):911-9. Review.

PMID:
21707481
5.

Liposomal drug delivery, a novel approach: PLARosomes.

Kozubek A, Gubernator J, Przeworska E, Stasiuk M.

Acta Biochim Pol. 2000;47(3):639-49. Review.

6.

Cationic liposomes as in vivo delivery vehicles.

Smyth Templeton N.

Curr Med Chem. 2003 Jul;10(14):1279-87. Review.

PMID:
12678799
7.

Mechanism of bioactive transfer through liposomal bilayers.

Maherani B, Arab-Tehrani E, Linder M.

Curr Drug Targets. 2011 Apr;12(4):531-45. Review.

PMID:
20863276
8.

[Ceramide pathway].

Wang YT, Sun CK, Ju G, Hu JL.

Sheng Li Ke Xue Jin Zhan. 1997 Oct;28(4):301-5. Review. Chinese.

PMID:
11038678
9.

[Ceramide and apoptosis].

Holopainen J, Mustonen P, Söderlund T, Tuominen E, Kinnunen P.

Duodecim. 1997;113(16):1605-11. Review. Finnish. No abstract available.

PMID:
10650628
10.

Evaluation of drug targeting strategies and liposomal trafficking.

Oku N, Tokudome Y, Asai T, Tsukada H.

Curr Pharm Des. 2000 Nov;6(16):1669-91. Review. No abstract available.

PMID:
10974160
11.

Preclinical development of a C6-ceramide NanoLiposome, a novel sphingolipid therapeutic.

Kester M, Bassler J, Fox TE, Carter CJ, Davidson JA, Parette MR.

Biol Chem. 2015 Jun;396(6-7):737-47. doi: 10.1515/hsz-2015-0129. Review.

PMID:
25838296

Supplemental Content

Support Center